AstraZeneca acquires Ardea Biosciences - MarketLine Financial Deals

AstraZeneca acquires Ardea Biosciences

AstraZeneca acquires Ardea Biosciences - MarketLine Financial Deals
AstraZeneca acquires Ardea Biosciences
Published Jun 19, 2012
5 pages — Published Jun 19, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

AstraZeneca PLC, a UK-based pharmaceutical company, has completed the acquisition of Ardea Biosciences, Inc.

  
Source:
Document ID
MA108207_120502
Country
Country
Ticker
AZN=GB
Ticker
RDEA=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "AstraZeneca acquires Ardea Biosciences" Jun 19, 2012. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/AstraZeneca-acquires-Ardea-Biosciences-2052-80922>
  
APA:
MarketLine Financial Deals. (2012). AstraZeneca acquires Ardea Biosciences Jun 19, 2012. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/AstraZeneca-acquires-Ardea-Biosciences-2052-80922>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.